Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Xeros Technology Names Vasopharm's Klaas De Boer As New Chair

13th Jan 2020 12:37

(Alliance News) - AIM-listed Xeros Technology Group PLC on Monday said it has appointed Klaas de Boer as chair to replace David Armfield, who will move to the position of senior independent director.

Xeros is water saving and filtration technologies provider.

De Boer is the managing partner of Entrepreneurs Fund Management LLP and holds positions on the boards of therapeutics firm Vasopharm, nuclear fusion company General Fusion and semiconductor inks manufacturer SmartKem.

"Klaas brings a wealth of experience in the funding and commercialisation of innovative products and important business connections including those within the COFRA group," said Xeros Chief Executive Mark Nichols.

He added: "Myself and the board thank David for his chairmanship during 2019, a period when the company achieved a number of major milestones and materially completed its migration to a license based business."

Xeros shares were up 2.2% on Monday in London at 1.09 pence each.

By Evelina Grecenko; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

Xeros Tech
FTSE 100 Latest
Value8,809.74
Change53.53